Skip to main content
Clinical Trials/ACTRN12609001004257
ACTRN12609001004257
Recruiting
Not Applicable

Obese adolescents in randomized control trial of the intragastric balloon and lifestyle intervention combination versus lifestyle intervention alone in reducing weight and associated health risks.

Dr Elizabeth Davis0 sites50 target enrollmentNovember 19, 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obesity in adolescents, and obesity-related comorbidities
Sponsor
Dr Elizabeth Davis
Enrollment
50
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 19, 2009
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Dr Elizabeth Davis

Eligibility Criteria

Inclusion Criteria

  • Participants must fulfil the following criteria:
  • 1\. Living in metropolitan Perth and willing to attend outpatient appointments.
  • 2\. No significant weight loss despite \= 3 months attempted lifestyle improvements.
  • Participants must have a BMI Z\-score \>\+3 OR a BMI Z\-score\>\+2 AND 2 or more of the following co\-morbidities.
  • 1\. Hyperlipidaemia
  • 2\. Impaired glucose tolerance/hyperinsulinaemia
  • 3\. Hepatitis steatosis
  • 4\. Hypertension,
  • 5\. Polycystic ovarian syndrome
  • 6\. Obstructive sleep apnoea

Exclusion Criteria

  • 1\. Previous gastrointestinal resections
  • 2\. Structural abnormalities of the gastrointestinal tract.
  • 3\. Psychiatric/eating disorder
  • 4\. Rural dwelling,
  • 5\. Active oesophagitis (Grade1\) / active gastric ulcer or its previous complications/hiatus hernia (\>5cm)
  • 6\. Pregnancy
  • 7\. Type 2 diabetes
  • 8\. Patient on anticoagulants or non\-steroidal anti\-inflammatory drugs gastric irritants, unwilling to make lifestyles changes or attend regular clinic appointments.
  • 9\. Unwilling to accept the probability of nausea and vomiting in the postoperative period.
  • 10\. Physical inability to maintain regular follow\-up

Outcomes

Primary Outcomes

Not specified

Similar Trials